Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904

Robert L. Coleman, James Moon, Anil K. Sood, Wei Hu, James E. Delmore, Albert J. Bonebrake, Garnet L. Anderson, Setsuko K. Chambers, Maurie Markman

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904'. Together they form a unique fingerprint.

Medicine & Life Sciences